The Column Group
thecolumngroup.com Direct investor
The Column Group is a venture capital firm focused on life sciences, investing in biotechnology companies from early-stage through later-stage. It has started and invested in 55 companies and generated $4.0 billion in returns.
The Column Group is a venture capital firm headquartered in San Francisco, United States, founded in 2007. It invests directly in companies, from seed to growth, in biotechnology, life sciences and therapeutics. 55 portfolio companies, as it reports.
“TCG deploys an edge-to-edge investment model, harnessing an ecosystem of funds that propel early technology platforms, single assets and later-stage programs forward from inception through exit.”
— The Column Group, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- San Francisco, United States
- Invests in
- US
- Sectors
- biotechnology, life sciences, therapeutics
- Founded
- 2007
- Portfolio
- 55 companies
Team, as The Column Group publishes it
- Peter Svennilson Founder / Managing Partner
- Tim Kutzkey Managing Partner
- Leon Chen Partner
- Sarah Hymowitz Partner
- James Evangelista Partner & Chief Financial Officer
- Jeff Goater Partner
- Hui Tian Partner
- Carla Daniel Partner & Chief People Officer
- John Josey Partner
- Craig Parker Venture Partner
- Arnav Mehta Venture Partner
Names and roles exactly as listed on thecolumngroup.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 43 co-investors found.
- Atlas Venture 5 shared companies: remixtx.com, accenttx.com, judo.bio, jnj.com…
- RA Capital Management 5 shared companies: novartis.com, atavistikbio.com, vrtx.com, synthekine.com…
- EcoR1 Capital 5 shared companies: accenttx.com, arcusbio.com, eikontx.com, oricpharma.com…
- TCG Crossover Management, LLC 4 shared companies: plexium.com, synthekine.com, eikontx.com, carmot.us
- Aisling Capital Management LP 4 shared companies: jnj.com, merck.com, arcusbio.com, gene.com
- Bain Capital Life Sciences 4 shared companies: vrtx.com, synthekine.com, revmed.com, nurixtx.com
- Foresite Capital 3 shared companies: merck.com, arcusbio.com, eikontx.com
- Red Cell Partners 2 shared companies: jnj.com, bms.com
- SpringRock Ventures 2 shared companies: jnj.com, merck.com
- venBio Partners LLC 2 shared companies: jnj.com, bms.com
and 33 more — the graph.
Where this comes from
Every fact above was read from a page The Column Group publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.thecolumngroup.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, portfolio_count, status
- https://www.thecolumngroup.com/tcg-team/founded, people
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 2135 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Atlas VentureVenture capital · Seed – Series A · Cambridge, United States
- Avalon BioVentures Management, LLCVenture capital · Seed – Series A · San Diego, United States
- Cure Ventures Management, LPVenture capital · Seed – Series A · Boston, United States
- EcoR1 CapitalVenture capital · San Francisco, United States
- Iaso VenturesVenture capital · Cambridge, United States
- Mission Bay CapitalVenture capital · Seed – Series A · San Francisco, United States